Global Update: Company Agrees to Share AIDS and Hepatitis Drugs With Patent Pool

Tuesday, July 12, 2011 - 10:40 in Mathematics & Economics

Gilead Sciences has agreed to license four of its drugs with the international Medicines Patent Pool, which will in turn license them to low-cost manufacturers.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net